The present disclosure generally relates to endoprosthetic devices for treating diseases of the vasculature, and more particularly to endoprosthetic devices comprising fenestrations or openings capable of receiving branch endoprosthetic devices.
Many endoprosthetic medical devices (or endoprostheses), such as, for example, stent-grafts, are constructed to reinforce, replace, bridge, or otherwise treat a part of a blood vessel. An endoprosthetic medical device may thus guide blood flow through a lumen defined by a generally tubular interior of such a vessel.
Occasionally, it may be necessary to implant an endoprosthetic device within a main vessel of a patient's body such that the device would, without adaptation, occlude or block one or more side-branch vessels extending from the main vessel. Thus, to permit blood to flow between a main vessel and a side branch vessel, certain fenestrated endoprosthetic devices have been developed. Endoprostheses of this type may be coupled to one or more side branch endoprostheses, so that blood is allowed to flow between a main vessel and a side branch vessel.
To this end, however, prior art endoprosthetic devices have included a variety of complex side branch endoprosthesis receiving portals. Thus, an improved fenestrated endoprosthesis and a method for deploying the same are desirable.
The features and advantages of the present disclosure will become more apparent from the detailed description set forth below when taken in conjunction with the drawings, wherein:
Persons skilled in the art will readily appreciate that various aspects of the present disclosure may be realized by any number of methods and apparatuses configured to perform the intended functions. Stated differently, other methods and apparatuses may be incorporated herein to perform the intended functions. It should also be noted that the accompanying drawing figures referred to herein are not all drawn to scale, but may be exaggerated to illustrate various aspects of the present disclosure, and in that regard, the drawing figures should not be construed as limiting. Finally, although the present disclosure may be described in connection with various principles and beliefs, the present disclosure should not be bound by theory.
The terms “branch vessel,” “branch,” “side-branch” and/or “side-branch vessel” can refer to a vessel that branches from a main or otherwise primary vessel. Likewise, a main or primary vessel can refer to any vessel from which a branch vessel branches.
The terms “endoprosthetic device” and “endoprosthesis” can refer to any medical device capable of being implanted and/or deployed within a body lumen. A “main endoprosthetic device” and/or a “main endoprosthesis” can refer to any medical device capable of being deployed within a first or main body lumen. A “branch endoprosthetic device” or “branch endoprosthesis” can refer, in like manner, to any medical device capable of being deployed within a second or branch body lumen. A branch endoprosthetic device can, in various embodiments, and as described herein, be coupled to a main endoprosthetic device.
Throughout this specification and in the claims, the term “proximal” refers to a location that is, or a portion of an endoprosthetic device that when implanted is, closer to the heart or a similar anatomical reference point. Similarly, the term “proximally” refers to a direction towards the heart or other reference point. Within a vessel or other body lumen, a movement may be in a proximal direction if such movement within the vessel or lumen would lead to the heart or other reference point.
Similarly, the term “distal” refers to a location that is, or a portion of an endoprosthetic device that when implanted is, farther from the heart or other reference point. Likewise, the term “distally” refers to a direction away from the heart or other reference point. Within a vessel or other body lumen, a movement may be in a distal direction if such movement within the vessel or lumen leads away from the heart or other reference point.
Notwithstanding the foregoing, since the present disclosure is not limited to peripheral or central approaches, the device should not be narrowly construed when using the terms proximal or distal since device features may be slightly altered relative to the anatomical features and the device position relative thereto.
As used herein, the term “constrain” may mean (i) to limit expansion, occurring either through self-expansion or expansion assisted by a device, of the diameter of an expandable implant, or (ii) to cover or surround, but not otherwise restrain, an expandable implant (e.g., for storage or biocompatibility reasons and/or to provide protection to the expandable implant and/or the vasculature).
While specific embodiments are described in greater detail below, in general, the present disclosure will focus primarily upon devices and methods for treating a body lumen, such as a blood vessel. In various embodiments, a main endoprosthetic device can comprise a side opening or fenestration, such as a slit or incision. The fenestration can be capable of two configurations: a first, closed, fluid impermeable or semi fluid impermeable configuration, and a second, open configuration.
The main endoprosthetic device can further comprise a layer of material coupled to an inner surface of the device. This layer can be referred to herein, as a “patch” or “support wall.” In various embodiments, the patch can cover the fenestration. Further, the patch can have a first portion and a second portion, both of which can receive, in various embodiments, a branch endoprosthetic device. These portions can comprise end or edge portions and can enable antegrade and/or retrograde flow between the main endoprosthetic device and the branch endoprosthetic device.
In various embodiments, the branch endoprosthetic device can be received by the first open end and/or the second open end of the patch and coupled to the main endoprosthetic device between the patch and an inner surface of the main endoprosthetic device. The patch can be distensible and can exert a pressure against the branch endoprosthetic device to couple or hold the branch device against the main endoprosthetic device within a support channel defined by a separation between the patch and the inner surface of the main endoprosthetic device. The branch endoprosthetic device can further exit or extend through the main endoprosthetic device at the fenestration.
Therefore, with reference now to
The endoprosthetic device 100 can further include a side opening, fenestration, or fenestrated portion 114. The fenestration 114 can comprise an opening, a slit, an incision, and the like. Further, in various embodiments, the fenestration 114 can comprise a weakened area and/or portion. Such a weakened portion can be perforated by a plurality of holes, scores, and the like. Similarly, a weakened portion can, relative to other portions of the main endoprosthetic device 100, comprise a thinner or less dense surface or material. Likewise, in various embodiments, a fenestration 114 can comprise a seal that can be broken (e.g., by a guidewire and/or a catheter).
The fenestration 114 can assume a variety of configurations. For example, the fenestration 114 can assume a closed configuration, in which the fenestration 114 remains substantially closed and/or fluid impermeable and/or substantially or semi fluid impermeable. In addition, the fenestration 114 can assume an open configuration, as shown, for example, at
The endoprosthetic device 100 can also comprise a layer of material such as a “support wall” or “patch” 108. The patch 108 can comprise a graft material, such as PTFE and/or ePTFE. The patch can be coupled to and/or disposed along an inner or luminal surface of the side wall 106. For example, the patch 108 can be joined or coupled to the side wall 106 along one or more of its longitudinal edges 110a and/or 110b. The patch may be variously joined to the side wall 106, e.g., via an adhesive substance, such as FEP or stitching. However, in various embodiments, the patch 108 is not joined to the side wall 106 along one or more of its latitudinal edges 112a and/or 112b. Further, in various embodiments, the patch 108 is not joined to the side wall 106 within a region interior to the edges 110a and 110b. Thus, the patch 108 can, together with the side wall 106, form a channel or pocket. Further, although the patch 108 is described herein with reference to one or more edges, in various embodiments, the patch 108 can comprise any shape.
The channel can, in certain embodiments, be flexible and/or distensible. For instance, the patch 108 can be distensible or movable between a closed configuration adjacent to the inner surface of the side wall 106 and an open configuration spaced apart from the inner surface of the side wall 106. In the open configuration, a channel (e.g., a support channel) can be formed between the inner surface of the side wall 106 and the patch 108. In various embodiments, the side wall 106 can also be somewhat flexible and/or distensible. As shown, the patch 108 can further overlap or cover the fenestration 114.
With reference to
To this end, a patch 108 can include one or more open portions, such as one or more open ends or edges. These open ends can be capable of receiving a branch endoprosthesis 202, and each end can act as an opening to the support channel, through which the branch endoprosthetic device can be coupled to the main endoprosthetic device. For example, with particular attention to
Thus, a branch endoprosthetic device 202 can be coupled to a main endoprosthetic device 100 via a support channel and exit a support channel at a fenestration 114 made in a side wall of the main endoprosthetic device 100. Moreover, as described herein, a fenestration 114 can remain substantially closed and/or fluid impermeable and/or substantially or semi fluid impermeable when the fenestration 114 is not opened by a branch endoprosthetic device 202. The patch 108 can further reduce and/or eliminate fluid flow between the fenestration 114 and the patch 108 when the patch 108 is in a closed configuration adjacent to the inner surface of the side wall 106. In addition, in various embodiments, a main endoprosthetic device 100 can include a plurality of fenestrations and/or a plurality of patches, each of which may couple a branch endoprosthetic device 202 to the main endoprosthetic 100. Thus, in various embodiments, a main endoprosthetic device 100 can be coupled to numerous branch endoprosthetic devices 202.
Fluid flow between the fenestration 114 and the patch 108 can be further reduced and/or eliminated by the introduction of a bond between at least a portion of the patch 108 and an inner surface of the side wall 106. Any suitable method can be used to form the bond between the patch 108 and the inner surface of the side wall 106. For example, the bond can be formed through the use of one or more adhesives, a heat bonding process, stitching, and the like. Adhesives can include any material suitable to the purpose, including, for example, FEP, PATT, and the like.
Thus, with attention to
Similarly, in various embodiments, the channel 302 can be pre-formed between the patch 108 and the inner surface of the side wall 106. For instance, the patch 108 can be joined to the side wall 106 except in the region comprising the channel 302. This configuration can permit easier access by a guidewire or catheter to the channel 302. In various embodiments, the channel 302 can comprise the support channel, as described herein, and/or the channel 302 can comprise a narrower precursor to the support channel 302, which can be opened or widened further by the insertion, for example, of a catheter and/or a branch endoprosthetic device 202 to form the support channel.
Turning to
In operation, and with attention now to
The catheter 800 can, in various embodiments, include or deliver a branch endoprosthetic device 202. The branch endoprosthetic device 202 can comprise an expandable (e.g., a balloon expandable) endoprosthesis and/or a self-expanding endoprosthesis. Further, the branch endoprosthetic device 202 can expand or deploy from a constrained diameter to an unconstrained diameter, as shown, while it is on the catheter 800. Thus, the branch endoprosthetic device 202 can expand within the distensible support channel, such that the branch device 202 is coupled, between the patch 108 and an inner surface of the side wall of the main endoprosthetic device 100, to the main endoprosthetic device 100. The deployed branch endoprosthetic device 202 can further expand within the fenestration 114, such that a relatively close (e.g., fluid impermeable and/or substantially fluid impermeable) seal is made between the branch device 202 and the main device 100. A deployed branch endoprosthetic device 202 is shown at
In various embodiments, as depicted at
In some embodiments, one or more of these gutters can be reduced, eliminated, and/or occluded by a branch endoprosthetic device 202. This can be accomplished by selecting one or more desired branch endoprosthetic device 202 shapes and/or materials which can fully or partially block or occlude one or more gutters. Thus, for example, a branch endoprosthetic device 202 can comprise a conformable material, such as a graft material, which is capable of conforming to fit within one or more of the gutters. Similarly, in various embodiments, one or more gutters can be reduced, eliminated, and/or occluded by a branch endoprosthetic device 202 that is preformed to fit within one or more of the gutters. Such a branch endoprosthetic device 202 can comprise, for example, a pinched or ellipsoidal shape. In addition, in various embodiments, a gutter can be reduced or eliminated by the inclusion of a strip of material (e.g., a thread or fiber) within or along the fenestration 114 and/or the within or along one of more of the open ends of the patch 108. These strips of material can be tightened or cinched to reduce or eliminate one or more gutters. Further, in various embodiments, a gutter can be reduced or occluded by utilizing a material, such as a flexible or compliant material (e.g., ePTFE) and/or a distensible and/or elastomeric material (e.g., any polymer and/or fluoropolymer, such as those described herein, and/or any fluoroelastomer and/or polyurethane), that is capable of conforming to encircle or ensconce the branch endoprosthetic device such that no gutters are formed and/or such that gutters are substantially reduced.
In addition, and with reference to
Similarly, and with reference to
Further, with attention to
However, as shown at
With reference to
In various embodiments, an endoprosthetic device 100 can be precannulated (that is, cannulated prior to implantation or deployment within a body lumen) by a variety of methods. For example, as shown with reference to
During deployment, and as shown now with reference to
Similarly, in various embodiments, a fenestration 114 can itself be precannulated. For instance, as shown with reference to
Prior to and/or during deployment, as shown with continuing reference to
A graft comprising any of the grafts and/or stent-grafts described above can be made up of any material which is suitable for use as a graft in the chosen body lumen. A graft can comprise one or a variety of materials. Furthermore, a graft can comprise multiple layers of material, which can be the same material or different material. Although a graft can have several layers of material, the graft can have a layer that is formed into a tube (innermost tube) and an outermost layer that is formed into a tube (outermost tube). In some embodiments, a graft can be fenestrated in-situ with a fenestration tool.
Many graft materials are known, and in various embodiments, these materials can be used in combination and assembled together to comprise a graft as well as a patch. These materials may be further extruded, coated and/or formed from wrapped films, and/or a combination thereof. Polymeric materials, biodegradable materials, and/or natural materials can be used for specific applications.
In various embodiments, a graft and/or patch can comprise synthetic polymers including nylon, polyacrylamide, polycarbonate, polyformaldehyde, polymethylmethacrylate, polytetrafluoroethylene, polytrifluorochlorethylene, polyvinylchloride, polyurethane, elastomeric organosilicon polymers, polyethylene, polypropylene, polyurethane, polyglycolic acid, polyesters, polyamides, their mixtures, blends, and copolymers. In a variety of embodiments, a graft can be made from a class of polyesters such as polyethylene terephthalate including DACRON® and MYLAR® and polyaramids such as KEVLAR®, polyfluorocarbons such as polytetrafluoroethylene (PTFE) with and without copolymerized hexafluoropropylene (TEFLON® or GORE-TEX®), and porous or nonporous polyurethanes. Further, in a variety of embodiments, a graft can comprise expanded fluorocarbon polymers (especially PTFE), materials.
In various embodiments, fluoropolymers can include polytetrafluoroethylene (PTFE), expanded PTFE (ePTFE), fluorinated ethylene propylene (FEP), copolymers of tetrafluoroethylene (TFE) and perfluoro (propyl vinyl ether) (PEA and/or PPVE), perfluoro ethyl vinyl ether (PEVE), perfluoro methy vinyl ether (PMVE), homopolymers of polychlorotrifluoroethylene (PCTFE), and its copolymers with TFE, ethylene-chlorotrifluoroethylene (ECTFE), copolymers of ethylene-tetrafluoroethylene (ETFE), polyvinylidene fluoride (PVDF), and polyvinylfluoride (PVF). In various embodiments, a graft and/or patch can comprise any combination of the materials listed above. Further, in various embodiments, a graft and/or patch can be substantially impermeable and/or permeable to bodily fluids. A substantially impermeable graft or patch can be made from materials that are substantially impermeable to bodily fluids or can be constructed from permeable materials treated or manufactured to be substantially impermeable to bodily fluids (e.g. by layering different types of materials described above or known in the art). In various embodiments, a stent-graft and/or a side-branch stent-graft, as described above, can be made from any combination of the materials described above, including ePTFE.
Any stent, including stent and/or stent members can be generally cylindrical when restrained and/or when unrestrained and may comprise helically arranged undulations having a plurality of helical turns. In a variety of embodiments, undulations can be aligned so that they are “in-phase” with each other. More specifically, undulations can comprise apices in opposing first and second directions. When these undulations are in-phase, apices in adjacent helical turns are aligned so that apices can be displaced into respective apices of a corresponding undulation in an adjacent helical turn. In certain embodiments, undulations can have a sinusoidal shape, a U shape, a V shape, and/or an ovaloid shape.
In various embodiments, a stent can be fabricated from a variety of biocompatible materials including commonly known materials (or combinations of materials) used in the manufacture of implantable medical devices. Such materials can include 316L stainless steel, cobalt-chromium-nickel-molybdenum-iron alloy (“cobalt-chromium”), other cobalt alloys such as L605, tantalum, nitinol, or other biocompatible metals. In some embodiments, any stent and/or stent-graft described herein can comprise a balloon expandable stent and/or stent-graft and/or a self-expanding stent and/or stent-graft. Further, in certain embodiments, a stent can comprise a wire wound stent, which may or may not comprise undulations.
Numerous characteristics and advantages have been set forth in the preceding description, including various alternatives together with details of the structure and function of the devices and/or methods. The disclosure is intended as illustrative only and as such is not intended to be exhaustive. It will be evident to those skilled in the art that various modifications can be made, especially in matters of structure, materials, elements, components, shape, size, and arrangement of parts including combinations within the principles of the invention, to the full extent indicated by the broad, general meaning of the terms in which the appended claims are expressed. To the extent that these various modifications do not depart from the spirit and scope of the appended claims, they are intended to be encompassed therein.
Number | Date | Country | |
---|---|---|---|
61793171 | Mar 2013 | US |